|
1
|
Khater MH, Abd El-Hassib DM, Sabry JH,
Elkilany RM and Ameen SG: Association between renalase gene
polymorphism (rs2296545) and hypertension in Egyptian chronic
kidney disease patients. Cureus. 15(e47903)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Murphy D, McCulloch CE, Lin F, Banerjee T,
Bragg-Gresham JL, Eberhardt MS, Morgenstern H, Pavkov ME, Saran R,
Powe NR, et al: Trends in prevalence of chronic kidney disease in
the United States. Ann Intern Med. 165:473–481. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Jha V, Garcia-Garcia G, Iseki K, Li Z,
Naicker S, Plattner B, Saran R, Wang AY and Yang CW: Chronic kidney
disease: Global dimension and perspectives. Lancet. 382:260–272.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mills KT, Xu Y, Zhang W, Bundy JD, Chen
CS, Kelly TN, Chen J and He J: A systematic analysis of worldwide
population-based data on the global burden of chronic kidney
disease in 2010. Kidney Int. 88:950–957. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mallamaci F and Tripepi G: Risk factors of
chronic kidney disease progression: Between old and new concepts. J
Clin Med. 13(678)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ahlawat RS, Gupta S, Kapoor S and Kar P:
Polymorphism of renalase gene in patients of chronic kidney
disease. Open J Nephrol. 2:136–143. 2012.
|
|
7
|
Naik RP, Derebail VK, Grams ME,
Franceschini N, Auer PL, Peloso GM, Young BA, Lettre G, Peralta CA,
Katz R, et al: Association of sickle cell trait with chronic kidney
disease and albuminuria in African Americans. JAMA. 312:2115–2125.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
O'Seaghdha CM, Parekh RS, Hwang SJ, Li M,
Köttgen A, Coresh J, Yang Q, Fox CS and Kao WH: The MYH9/APOL1
region and chronic kidney disease in European-Americans. Hum Mol
Genet. 20:2450–2456. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ameer QZ: Hypertension in chronic kidney
disease: What lies behind the scene. Front Pharmacol.
13(949260)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Erfanpoor S, Etemad K, Kazempour S,
Hadaegh F, Hasani J, Azizi F, Parizadeh D and Khalili D: Diabetes,
hypertension, and incidence of chronic kidney disease: Is there any
multiplicative or additive interaction? Int J Endocrinol Metab.
19(e101061)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kushwaha R, Vardhan PS and Kushwaha PP:
Chronic kidney disease interplay with comorbidities and
carbohydrate metabolism: A review. Life (Basel).
14(13)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gerich JE: Physiology of glucose
homeostasis. Diabetes Obes Metab. 2:345–350. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kamal A: Estimation of blood urea (Bun)
and serum creatinine level in patients of renal disorder. Indian J
Fundam Appl Life Sci. 4:199–202. 2014.
|
|
14
|
Lousa I, Reis F, Beirão I, Alves R, Belo L
and Santos-Silva A: New potential biomarkers for chronic kidney
disease management-a review of the literature. Int J Mol Sci.
22(43)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rehberg PB: Studies on kidney function:
The rate of filtration and reabsorption in the human kidney.
Biochem J. 20:447–460. 1926.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bosch JP, Saccaggi A, Lauer A, Ronco C,
Belledonne M and Glabman S: Renal functional reserve in humans.
Effect of protein intake on glomerular filtration rate. Am J Med.
75:943–950. 1983.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Waikar SS and Bonventre JV: Creatinine
kinetics and the definition of acute kidney injury. J Am Soc
Nephrol. 20:672–679. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stevens PE and Levin A: KDIGO 2012
clinical practice guideline for the evaluation and management of
chronic kidney disease. Ann Intern Med. 3:825–831. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gafter-Gvili A, Schechter A and Rozen-Zvi
B: Iron deficiency anemia in chronic kidney disease. Acta Haematol.
142:44–50. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gaweda AE: Markers of iron status in
chronic kidney disease. Hemodial Int. 21 (Suppl 1):S21–S27.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Poojar B, Ommurugan B, Adiga S, Thomas H,
Sori RK, Poojar B, Hodlur N, Tilak A, Korde R and Gandigawad P:
Methodology Used in the Study. Asian J Pharm Clin Res. 7:1–5.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Omari Shekaftik S and Nasirzadeh N:
8-Hydroxy-2'-deoxyguanosine (8-OHdG) as a biomarker of oxidative
DNA damage induced by occupational exposure to nanomaterials: A
systematic review. Nanotoxicology. 15:850–864. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jacobson MH, Liu M, Wu Y, Furth S, Warady
B, Trachtman H and Trasande L: Oxidant stress and renal function
among children with chronic kidney disease: A repeated measures
study. Sci Rep. 10(3129)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Okamura DM and Himmelfarb J: Tipping the
redox balance of oxidative stress in fibrogenic pathways in chronic
kidney disease. Pediatr Nephrol. 24:2309–2319. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Honda T, Hirakawa Y and Nangaku M: The
role of oxidative stress and hypoxia in renal disease. Kidney Res
Clin Pract. 38:414–426. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Goriuc A, Cojocaru KA, Luchian I, Ursu RG,
Butnaru O and Foia L: Using 8-hydroxy-2'-deoxiguanosine (8-OHdG) as
a reliable biomarker for assessing periodontal disease associated
with diabetes. Int J Mol Sci. 25(1425)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dhondup T and Qian Q: Acid-base and
electrolyte disorders in patients with and without chronic kidney
disease: An update. Kidney Dis (Basel). 3:136–148. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ray L, Nanda SK, Chatterjee A, Sarangi R
and Ganguly S: A comparative study of serum aminotransferases in
chronic kidney disease with and without end-stage renal disease:
Need for new reference ranges. Int J Appl Basic Med Res. 5:31–35.
2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cheng T, Wang X, Han Y, Hao J, Hu H and
Hao L: The level of serum albumin is associated with renal
prognosis and renal function decline in patients with chronic
kidney disease. BMC Nephrol. 24(57)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mehmood HR, Khan Z, Jahangir HMS, Hussain
A, Elahi A and Askari SMH: Assessment of serum biochemical
derangements and associated risk factors of chronic kidney disease.
J Taibah Univ Med Sci. 17:376–383. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kuhn C, Mohebbi N and Ritter A: Metabolic
acidosis in chronic kidney disease: Mere consequence or also
culprit? Pflugers Arch. 476:579–592. 2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Poznyak AV, Sadykhov NK, Kartuesov AG,
Borisov EE, Sukhorukov VN and Orekhov AN: Atherosclerosis specific
features in chronic kidney disease (CKD). Biomedicines.
10(2094)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li J, Liu D and Liu Z: Serum Total
bilirubin and progression of chronic kidney disease and mortality:
A systematic review and meta-analysis. Front Med (Lausanne).
7(549)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Taliercio JJ, Schold JD, Simon JF,
Arrigain S, Tang A, Saab G, Nally JV Jr and Navaneethan SD:
Prognostic importance of serum alkaline phosphatase in CKD stages
3-4 in a clinical population. Am J Kidney Dis. 62:703–710.
2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gluba-Brzózka A, Franczyk B, Olszewski R
and Rysz J: The influence of inflammation on anemia in CKD
patients. Int J Mol Sci. 21(725)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
McClellan WM, Flanders WD, Langston RD,
Jurkovitz C and Presley R: Anemia and renal insufficiency are
independent risk factors for death among patients with congestive
heart failure admitted to community hospitals: A population-based
study. J Am Soc Nephrol. 13:1928–1936. 2002.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Guerra F, Di Giacomo D, Ranieri J, Tunno
M, Piscitani L and Ferri C: Chronic kidney disease and its
relationship with mental health: Allostatic load perspective for
integrated care. J Pers Med. 11(1367)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mizdrak M, Kumrić M, Kurir TT and Božić J:
Emerging biomarkers for early detection of chronic kidney disease.
J Pers Med. 12(548)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Vallianou NG, Mitesh S, Gkogkou A and
Geladari E: Chronic kidney disease and cardiovascular disease: Is
there any relationship? Curr Cardiol Rev. 15:55–63. 2019.
|
|
40
|
Al-Wahsh H, Lam NN, Liu P, Quinn RR,
Fiocco M, Hemmelgarn B, Tangri N, Tonelli M and Ravani P:
Investigating the relationship between age and kidney failure in
adults with category 4 chronic kidney disease. Can J Kidney Heal
Dis. 7(2054358120966819)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Nguyen A, Khafagy R, Gao Y, Meerasa A,
Roshandel D, Anvari M, Lin B, Cherney DZI, Farkouh ME, Shah BR, et
al: Erratum. Association between obesity and chronic kidney
disease: multivariable mendelian randomization analysis and
observational data from a bariatric surgery cohort. Diabetes
2023;72:496-510. Diabetes. 72(1174)2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Prasad R, Jha RK and Keerti A: Chronic
kidney disease: Its relationship with obesity. Cureus.
14(e30535)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yang S, Ling J, Zhang S, Li Y and Yang G:
Metabolic dysfunction, rather than obesity, is a risk factor for
chronic kidney disease in Chinese population. Aging Male.
27(2335158)2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Mather A and Pollock C: Glucose handling
by the kidney. Kidney Int. 79 (Suppl 120):S1–S6. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wright EM, Hirayama BA and Loo DF: Active
sugar transport in health and disease. J Intern Med. 261:32–43.
2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Merzah KS and Hasson SF: The biochemical
changes in patients with chronic renal failure. Int J Pharma Med
Biol Sci. 4:75–79. 2015.
|
|
47
|
Nisha R, Srinivasa Kannan SR, Thanga
Mariappan K and Jagatha P: Biochemical evaluation of creatinine and
urea in patients with renal failure undergoing hemodialysis. J Clin
Pathol Lab Med. 1:1–5. 2017.
|
|
48
|
Pandya D, Nagrajappa AK and Ravi KS:
Assessment and correlation of urea and creatinine levels in saliva
and serum of patients with chronic kidney disease, diabetes and
hypertension-A research study. J Clin Diagnostic Res. 10:ZC58–ZC62.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Fujisawa H, Nakayama M, Haruyama N, Fukui
A, Yoshitomi R, Tsuruya K, Nakano T and Kitazono T: Association
between iron status markers and kidney outcome in patients with
chronic kidney disease. Sci Rep. 13(18278)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Cavalcanti Sette LHB and de Almeida Lopes
EP: Liver enzymes serum levels in patients with chronic kidney
disease on hemodialysis: A comprehensive review. Clinics (Sao
Paulo). 69:271–278. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Sabouri S, Afzal Aghaee M, Lotfi Z,
Esmaily H, Alizadeh M and Mozafari HM: Evaluation of liver enzymes
in end-stage renal disease patients on the renal transplant-waiting
list in north-west of Iran. Nephrourol Mon. 12(e107859)2020.
|
|
52
|
Crawford DR, Reyna RS and Weiner MW:
Effects of in vivo and in vitro dialysis on plasma transaminase
activity. Nephron. 22:418–422. 1978.PubMed/NCBI View Article : Google Scholar
|
|
53
|
El-Khoury JM and Wang S: Aspartate
aminotransferase and alanine aminotransferase. In: Kazmierczak SC,
Azzazy HME (eds). Diagnostic Enzymology. Berlin, Germany: De
Gruyter, pp81-104, 2014.
|
|
54
|
Cohen DL and Townsend RR: Central blood
pressure and chronic kidney disease progression. Int J Nephrol.
2011(407801)2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Beddhu S, Ma X, Baird B, Cheung AK and
Greene T: Serum alkaline phosphatase and mortality in African
Americans with chronic kidney disease. Clin J Am Soc Nephrol.
4:1805–1810. 2009.PubMed/NCBI View Article : Google Scholar
|
|
56
|
O'Rourke MF and Safar ME: Relationship
between aortic stiffening and microvascular disease in brain and
kidney: Cause and logic of therapy. Hypertension. 46:200–204.
2005.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gatua WK, Ngeranwa JJN and Mbugua P: The
effects of chronic kidney disease on liver function tests: The
laboratory interpretation perspective. Asian J Med Sci. 10:13–18.
2019.
|
|
58
|
Molla MD, Degef M, Bekele A, Geto Z,
Challa F, Lejisa T, Getahun T, Sileshi M, Tolcha Y, Ashebir G and
Seifu D: Assessment of serum electrolytes and kidney function test
for screening of chronic kidney disease among ethiopian public
health institute staff members, Addis Ababa, Ethiopia. BMC Nephrol.
21(494)2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Lobo V, Patil A, Phatak A and Chandra N:
Free radicals, antioxidants and functional foods: Impact on human
health. Pharmacogn Rev. 4:118–126. 2010.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Tarng DC, Wen Chen T, Huang TP, Chen CL,
Liu TY and Wei YH: Increased oxidative damage to peripheral blood
leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc
Nephrol. 13:1321–1330. 2002.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Sanchez M, Roussel R, Hadjadj S, Moutairou
A, Marre M, Velho G and Mohammedi K: Plasma concentrations of
8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in
individuals with type 1 diabetes. Diabetologia. 61:977–984.
2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Wojtaszek E, Oldakowska-Jedynak U,
Kwiatkowska M, Glogowski T and Malyszko J: Uremic toxins, oxidative
stress, atherosclerosis in chronic kidney disease, and kidney
transplantation. Oxid Med Cell Longev. 2021(6651367)2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Zoccali C, Mallamaci F, Adamczak M, de
Oliveira RB, Massy ZA, Sarafidis P, Agarwal R, Mark PB, Kotanko P,
Ferro CJ, et al: Cardiovascular complications in chronic kidney
disease: A review from the European renal and cardiovascular
medicine working group of the European renal association.
Cardiovasc Res. 119:2017–2032. 2023.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Begum S and Latunde-Dada GO: Anemia of
inflammation with an emphasis on chronic kidney disease. Nutrients.
11(2424)2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Lewandowski MJ, Krenn S, Kurnikowski A,
Bretschneider P, Sattler M, Schwaiger E, Antlanger M, Gauckler P,
Pirklbauer M, Brunner M, et al: Chronic kidney disease is more
prevalent among women but more men than women are under
nephrological care: Analysis from six outpatient clinics in Austria
2019. Wien Klin Wochenschr. 135:89–96. 2023.PubMed/NCBI View Article : Google Scholar
|
